Elsevier

Biochemical Pharmacology

Volume 56, Issue 6, 15 September 1998, Pages 675-682
Biochemical Pharmacology

Commentaries
The Hsp90 complex—a super-chaperone machine as a novel drug target

https://doi.org/10.1016/S0006-2952(98)00120-8Get rights and content

Abstract

Cells respond to sudden changes in the environmental temperature with increased synthesis of a distinct number of heat shock proteins (Hsps). Analysis of the function of these proteins in recent years has shown that all the major classes of conserved Hsps are molecular chaperones involved in assisting cellular protein folding and preventing irreversible side-reactions, such as unspecific aggregation. In addition to their function under stress conditions, molecular chaperones also play a critical role under physiological conditions. Hsp90 is one of the most abundant chaperones in the cytosol of eukaryotic cells. It is part of the cell’s powerful network of chaperones to fight the deleterious consequences of protein unfolding caused by nonphysiological conditions. In the absence of stress, however, Hsp90 is an obligate component of fundamental cellular processes such as hormone signaling and cell cycle control. In this context, several key regulatory proteins, such as steroid receptors, cell cycle kinases, and p53, have been identified as substrates of Hsp90. Recently, Hsp90 was shown to be the unique target for geldanamycin, a potent new anti-tumor drug that blocks cell proliferation. Interestingly, under physiological conditions, Hsp90 seems to perform its chaperone function in a complex with a set of partner proteins, suggesting that the Hsp90 complex is a multi-chaperone machine specialized in guiding the maturation of conformationally labile proteins. The regulation of key signaling molecules of the cell by the Hsp90 machinery is a stimulating new concept emerging from these studies, and Hsp90 has become a promising new drug target.

Section snippets

Role of Hsp90 in the conformational regulation of proteins in vivo

The first indication of the cellular function of Hsp90s in higher eukaryotes was the surprising discovery that a major protein coprecipitating with steroid hormone receptors in the absence of hormone was identical to Hsp90 4, 5. These complexes were stable because they survived immunoprecipitation. Later on, it was shown that the addition of steroid hormone causes the apparent dissociation of the complex and the dimerization of the receptor, which is required for DNA binding and transcriptional

Dissection of Hsp90 function

Proteolysis experiments and sequence alignments suggested that Hsp90 is composed of several domains including two highly conserved regions common to all members of the Hsp90 family, separated by a highly charged region of varying length [1](Fig. 1). The function of the charged region remains elusive, since its deletion in yeast Hsp90 did not result in a detectable phenotype in vivo[28]. The structure of the N-terminal domain of Hsp90 has been solved by x-ray crystallography 29, 30, 31. This

Hsp90 as the central platform of distinct multi-chaperone complexes

At least for some non-native proteins such as steroid receptors and kinases, Hsp90 functions in concert with a well-defined set of cofactors (Table 1and Fig. 3), which are essential to drive the cycle of Hsp90–substrate interaction. The existence of these heteroprotein complexes could be demonstrated even in the absence of specific substrate proteins [5], leading to the assumption that they may represent “super chaperone complexes” [37].

In the case of steroid receptor activation, a number of

Hsp90 as the target of the novel anti-tumor drug geldanamycin

Recently, Hsp90 surfaced as the target for a potent new anti-tumor drug. Screens of natural compounds for substances inhibiting the proliferation of tumor cells identified the benzochinone ansamycin GA as a promising candidate 67, 68. GA from Streptomyces hygroscopicus var. geldanus and some natural analogs from various Nocardia species inhibited growth of a large number of cancer cell lines when administered in the sub-micromolar range [69]. Initially, GA was supposed to be an inhibitor for

Conclusion

The first identifications of certain classes of proteins as natural substrates of Hsp90 suggested that, in contrast to the other promiscuous chaperones, Hsp90 is a specific or dedicated chaperone [46]. However, the basis for this potential specificity remains enigmatic since the structures of kinases and steroid receptors do not share obvious common structural elements. Furthermore, this specificity would not explain the necessity of increased Hsp90 expression (up to 15-fold) under stress

Acknowledgements

We thank Christian Mayr and Martina Beissinger for assistance in artwork, Franziska Pirkl and Stefan Bell for critically reading the manuscript, Lawrence Pearl for sharing coordinates, and David Smith for detailed comments on receptor cycles. Work in Dr. Buchner’s laboratory was supported by the Deutsche Forschungs-gemeinschaft, Bundesministerium fuer Bildung, Wissenschaft, Forschung und Technologie, and the Fonds der chemischen Industrie.

References (76)

  • T. Scheibel et al.

    ATP-binding properties of human Hsp90

    J Biol Chem

    (1997)
  • S.P. Bohen

    Hsp90 mutants disrupt glucocorticoid receptor ligand binding and destabilize aporeceptor complexes

    J Biol Chem

    (1995)
  • T. Ziegelhoffer et al.

    The dissociation of ATP from hsp70 of Saccharomyces cerevisiae is stimulated by both Ydj1p and peptide substrates

    J Biol Chem

    (1995)
  • R.J. Schumacher et al.

    ATP-dependent chaperoning activity of reticulocyte lysate

    J Biol Chem

    (1994)
  • M.S. Chen et al.

    The tetratricopeptide repeat domain of protein phosphatase 5 mediates binding to glucocorticoid receptor heterocomplexes and acts as a dominant negative mutant

    J Biol Chem

    (1996)
  • J.K. Owens-Grillo et al.

    A model of protein targeting mediated by immunophilins and other proteins that bind to Hsp90 via tetratricopeptide repeat domains

    J Biol Chem

    (1996)
  • H.C.J. Chang et al.

    Conservation of Hsp90 macro-molecular complexes in Saccharomyces cerevisiae

    J Biol Chem

    (1994)
  • T.W. Schulte et al.

    Disruption of the Raf-1–Hsp90 molecular complex results in destabilization of Raf-1 and loss of Raf-1-Ras association

    J Biol Chem

    (1995)
  • T. Scheibel et al.

    The Hsp90 family—An overview

  • K.A. Borkovich et al.

    Hsp82 is an essential protein that is required in higher concentrations for growth of cells at higher temperatures

    Mol Cell Biol

    (1989)
  • M.G. Catelli et al.

    The common 90-kd protein component of non-transformed ‘8S’ steroid receptors is a heat-shock protein

    EMBO J

    (1985)
  • W.B. Pratt et al.

    Steroid receptor interactions with heat shock protein and immunophilin chaperones

    Endocr Rev

    (1997)
  • S.P. Bohen et al.

    Modulation of steroid receptor signal transduction by heat shock proteins

  • J.S. Brugge

    Interaction of the Rous sarcoma virus protein pp60src with the cellular proteins pp50 and pp90

    Curr Microbiol Immunol

    (1986)
  • Y. Xu et al.

    Heat shock protein Hsp90 governs the activity of v-src kinase

    Proc Natl Acad Sci USA

    (1993)
  • A. van der Straten et al.

    The heat shock protein 83 (Hsp83) is required for Raf-mediated signalling in Drosophila

    EMBO J

    (1997)
  • J. Melnick et al.

    Sequential interaction of the chaperones BiP and GRP94 with immunoglobulin chains in the endoplasmic reticulum

    Nature

    (1994)
  • U. Tatu et al.

    Interactions between newly synthesized glycoproteins, calnexin and a network of resident chaperones in the endoplasmic reticulum

    J Cell Biol

    (1997)
  • J. Hu et al.

    Hsp90 is required for the activity of a hepatitis B virus reverse transcriptase

    Proc Natl Acad Sci USA

    (1996)
  • J. Hu et al.

    Hepadnavirus assembly and reverse transcription require a multi-component chaperone complex which is incorporated into nucleocapsids

    EMBO J

    (1997)
  • J. Bartek et al.

    Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines

    Oncogene

    (1990)
  • M.V. Blagosklonny et al.

    Geldanamycin selectively destabilizes and conformationally alters mutated p53

    Oncogene

    (1995)
  • M.V. Blagosklonny et al.

    Mutant conformation of p53 translated in vitro or in vivo requires functional Hsp90

    Proc Natl Acad Sci USA

    (1996)
  • L. Whitesell et al.

    Geldanamycin-stimulated destabilization of mutated p53 is mediated by the proteasome in vivo

    Oncogene

    (1997)
  • C. Schneider et al.

    Pharmacological shifting of a balance between protein refolding and degradation mediated by Hsp90

    Proc Natl Acad Sci USA

    (1996)
  • Z. Li et al.

    Tumor rejection antigen gp96/grp94 is an ATPaseImplications for protein folding and antigen presentation

    EMBO J

    (1993)
  • N.E. Blachere et al.

    Heat shock protein–peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity

    J Exp Med

    (1997)
  • S.J. Ullrich et al.

    A mouse tumor-specific transplantation antigen is a heat-shock related protein

    Proc Natl Acad Sci USA

    (1986)
  • Cited by (165)

    • The heat shock protein 90 inhibitor, 17-AAG, attenuates thioacetamide induced liver fibrosis in mice

      2016, Pharmacological Reports
      Citation Excerpt :

      According to their molecular weight, Hsp are classified into Hsp10, Hsp40, Hsp70, Hsp90 and others. They act as chaperones with definite roles in protein folding, assembly and transport associating cell-cycle control and protection against stress [1,2]. One of these proteins is Hsp90 that was originally discovered with more abundance upon heat stress.

    • Hsp90 - a potential prognostic marker in CML

      2013, Blood Cells, Molecules, and Diseases
    View all citing articles on Scopus
    View full text